Is it normal to have high alpha-fetoprotein after liver cancer surgery? Not normal

Is it normal to have high alpha-fetoprotein after liver cancer surgery? I believe many people are familiar with liver cancer. If this disease is not treated, the patient's survival time is not long, so it is necessary to seize the time for treatment. So, let's find out whether it is normal to have high alpha-fetoprotein after liver cancer surgery?

AFP can be used as an important indicator for HCC tracking and observation. Generally, serum AFP decreases significantly after surgery or chemotherapy, which is called surgery or chemotherapy, liver metastasis; if AFP rises again after a period of time, it may be recurrent hepatocellular carcinoma. In fact, except for individual diseases, malignant tumors are treated in some way or with a single drug. The effect is not good. There must be multiple methods for reasonable comprehensive treatment. Good arrangement can significantly prolong the patient's survival time. Therefore, these things can be confirmed very well.

For patients with extrahepatic lesions, systemic treatment and local treatment of liver cancer lesions should be organically combined to achieve good results. For patients with pleural effusion, the problem of pleural effusion should be solved as soon as possible, and injections can be made into the pleural and abdominal cavities, or biological agents can be injected.

Ascites disappears, the body can effectively improve the patient's beneficial systemic treatment. If the rapid development is localized, local disease control should be carried out according to radiological interventional treatment. At the same time, immune products can be used to strengthen the body, which can not only shrink the liver cancer lesions, but also reduce the adverse reactions of light radiation. Effective traditional Chinese medicine for postoperative consolidation treatment of liver cancer, it is recommended that you use Chinese medicine Cordyceps and Poria. With the use of these traditional Chinese medicines, the spread and metastasis of cancer cells can be effectively controlled, the body's immune function can be enhanced to inhibit the growth of tumor cells, enhance the body's immunity, and ultimately achieve the goal of defeating cancer, and can prevent residual cancer cells and prevent recurrence and metastasis.

It is often said that most primary liver cancers. Primary hepatocellular carcinoma (HCC) is one of the most common malignant tumors in the world. According to the latest statistics, there are about 600,000 liver cancer patients in the world every year, which is a large number of deaths.